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OBJECTIVES: The consumption of Chinese herbal products
(CHPs) is increasing exponentially. However, the scientiﬁc evi-
dence is lacking and there is an urgent requirement for detailed
pharmacoepidemiological information on CHP usage. This study
was to investigate CHP prescription patterns in Taiwan.
METHODS: We carried out a cross-sectional analysis on a
cohort of 200,000 patients, based on 2004 data from the
National Health Insurance (NHI) reimbursement database. Data
mining techniques were applied to explore CHP co-prescription
patterns. RESULTS: A total of 46,938 patients had been pre-
scribed CHPs on at least one occasion in 2004. Patients using
CHPs were generally female and middle-aged, made more out-
patient visits, had fewer hospitalizations and consumed more
medical resources than non-users of CHPs. A total of 1,073,030
CHPs were contained within 220,123 prescriptions, for which
acute nasopharyngitis was the most common indication. Yan hu
suo and Jia Wei Xiao Yao San were the most frequently pre-
scribed single herb (SH) and herbal formula (HF), respectively.
The results of the data mining showed that the best predic-
tions were provided by co-prescriptions of “Mo yao and Ru
xiang”, “Ye jiao teng and Suan Zao Ren Tan” and
“Dang Gui Nian Tong Tang and Shu Jing Huo Xue Tang”
in the groups of SH-SH, SH-HF and HF-HF, respectively.
CONCLUSIONS: This study provides national-level CHP pre-
scription proﬁles and utilization rates, and documents, for the
ﬁrst time, HF-HF prescription combinations in Chinese medicine
practices in Taiwan. We conclude that more studies are needed to
validate the safety and effectiveness of CHP prescriptions.
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OBJECTIVE: Off-label prescription use can be a valuable source
of innovation and is often supported by considerable evidence.
However, many uses are not supported by evidence and unregu-
lated off-label usemay expose patients to serious harm.We sought
to examine physicians’ knowledge, attitudes, and experiences
regarding off-label use. METHODS: Ongoing nationally repre-
sentative random-sample mail survey of general internists and
psychiatrists. Knowledge of approved indications was assessed
using a list of 15 speciﬁc drug-indication pairs for each specialty
that varied in their clinical applications and levels of supporting
evidence. RESULTS: There were 166 respondents at the time of
abstract submission (14% preliminary response rate); 67% were
psychiatrists and 33% internists. Of the drug-indication pairs
examined among general internists, use of the drug for the speci-
ﬁed off-label indication varied from 24% (venlafaxine for adjust-
ment disorder) to 87% (lisinopril for diabetic proteinuria) (mean
59%). Of these instances, physicians accurately identiﬁed the
off-label status in less than half of the cases, ranging from 22%
correct identiﬁcation that escitalopram was off-label for panic
disorder to 71% comﬁrmation that trazadone was off-label for
insomnia (mean 36%). Results were substantively similar among
psychiatrists; there was common use of speciﬁc drugs for off-label
indications, despite poor to moderate knowledge of the labeling
status of the use. Overall, the most important factors associated
with off-label were practice guidelines or references (26%), suc-
cessful off-label use in other patients (24%), and the absence of a
labeled alternative (14%). CONCLUSION: These preliminary
ﬁndings suggest that practicing internists and psychiatrists may
not have precise knowledge of the FDA approved indications of
the drugs they prescribe. Given how commonly off-label use
occurs, further work is needed to better delineate and communi-
cate the levels of evidence that should be incorporated in clinical
decision-making to guide optimal prescribing.
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OBJECTIVE: Drug interactions have been associated with
increased incidence of adverse events, hospitalizations, and
death. Our objective was to determine the degree of knowledge
of clinically signiﬁcant DDIs by third- and fourth-year pharmacy
students. METHODS: Two independent questionnaires designed
to measure knowledge of DDIs were utilized in this analysis.
Both questionnaires asked students to categorize the potential
severity of various DDI pairs. The ﬁrst questionnaire was dis-
seminated to fourth year Class of 2005 pharmacy students
(n = 68) at one school of pharmacy and consisted of 22 DDI
pairs. A second questionnaire was distributed to third-year Class
of 2007 pharmacy students at two schools of pharmacy (School
A, n = 70; School B, n = 120) and it contained ten DDI pairs for
students to categorize. A year later, the second questionnaire was
re-administered to Class of 2007 students at School A (n = 75).
RESULTS: Forty-seven (69%) fourth year pharmacy students
completed the ﬁrst questionnaire. Respondents correctly catego-
rized an average (SD) of 42% (12%) of the DDI pairs. Sixty-six
(94%) and 115 (96%) of third year pharmacy students from
School A and School B, respectively, completed the question-
naire. The average (SD) number of drug interaction questions
answered correctly by third year students was 56% (18%) at
School A and 59% (16%) at School B, p = 0.22. Forty-three
(57%) fourth year students from the Class of 2007 completed the
questionnaire and the average percentage of correct responses
was 59% (17%), p = 0.36 for third year versus fourth year
Class of 2007 students from School A. CONCLUSION: This
study suggests that pharmacy student knowledge of DDIs is
poor. Modiﬁcations in pharmacy school curriculum may be
necessary to increase students’ ability to correctly identify drug
interactions.
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